138 related articles for article (PubMed ID: 12406874)
21. Mixed chimerism induced without lethal conditioning prevents T cell- and anti-Gal alpha 1,3Gal-mediated graft rejection.
Ohdan H; Yang YG; Shimizu A; Swenson KG; Sykes M
J Clin Invest; 1999 Aug; 104(3):281-90. PubMed ID: 10430609
[TBL] [Abstract][Full Text] [Related]
22. The α-Gal epitope (Galα1-3Galβ1-4GlcNAc-R) in xenotransplantation.
Galili U
Biochimie; 2001 Jul; 83(7):557-63. PubMed ID: 11522383
[TBL] [Abstract][Full Text] [Related]
23. Hyperacute rejection of vascularized heart transplants in BALB/c Gal knockout mice.
Gock H; Salvaris E; Murray-Segal L; Mottram P; Han W; Pearse MJ; Goodman DJ; Cowan PJ; d'Apice AJ
Xenotransplantation; 2000 Nov; 7(4):237-46. PubMed ID: 11081758
[TBL] [Abstract][Full Text] [Related]
24. Intratumoral injection of alpha-gal glycolipids induces xenograft-like destruction and conversion of lesions into endogenous vaccines.
Galili U; Wigglesworth K; Abdel-Motal UM
J Immunol; 2007 Apr; 178(7):4676-87. PubMed ID: 17372027
[TBL] [Abstract][Full Text] [Related]
25. Expression of alpha-gal epitopes on ovarian carcinoma membranes to be used as a novel autologous tumor vaccine.
Galili U; Chen ZC; DeGeest K
Gynecol Oncol; 2003 Jul; 90(1):100-8. PubMed ID: 12821349
[TBL] [Abstract][Full Text] [Related]
26. The Role of Liver Sinusoidal Endothelial Cells in Induction of Carbohydrate Reactive B Cells Tolerance Through the Programmed Death 1/Programmed Death Ligand 1 Pathway.
Igarashi Y; Onoe T; Ohdan H
Transplantation; 2015 Nov; 99(11):2325-36. PubMed ID: 26247556
[TBL] [Abstract][Full Text] [Related]
27. Immunogenicity of influenza virus vaccine is increased by anti-gal-mediated targeting to antigen-presenting cells.
Abdel-Motal UM; Guay HM; Wigglesworth K; Welsh RM; Galili U
J Virol; 2007 Sep; 81(17):9131-41. PubMed ID: 17609270
[TBL] [Abstract][Full Text] [Related]
28. Anti-Gal-mediated targeting of human B lymphoma cells to antigen-presenting cells: a potential method for immunotherapy using autologous tumor cells.
Manches O; Plumas J; Lui G; Chaperot L; Molens JP; Sotto JJ; Bensa JC; Galili U
Haematologica; 2005 May; 90(5):625-34. PubMed ID: 15921377
[TBL] [Abstract][Full Text] [Related]
29. Sequential analysis of anti-alpha Gal natural antibody-producing B cells in GalT knockout mice in cyclophosphamide-induced tolerance.
Shimizu I; Tomita Y; Iwai T; Kajiwara T; Okano S; Nomoto K; Tominaga R
Scand J Immunol; 2006 Jun; 63(6):435-43. PubMed ID: 16764697
[TBL] [Abstract][Full Text] [Related]
30. Evolution and pathophysiology of the human natural anti-alpha-galactosyl IgG (anti-Gal) antibody.
Galili U
Springer Semin Immunopathol; 1993; 15(2-3):155-71. PubMed ID: 7504839
[TBL] [Abstract][Full Text] [Related]
31. Tolerization of anti-Galalpha1-3Gal natural antibody-forming B cells by induction of mixed chimerism.
Yang YG; deGoma E; Ohdan H; Bracy JL; Xu Y; Iacomini J; Thall AD; Sykes M
J Exp Med; 1998 Apr; 187(8):1335-42. PubMed ID: 9547344
[TBL] [Abstract][Full Text] [Related]
32. The xenoantibody response and immunoglobulin gene expression profile of cynomolgus monkeys transplanted with hDAF-transgenic porcine hearts.
Zahorsky-Reeves JL; Kearns-Jonker MK; Lam TT; Jackson JR; Morris RE; Starnes VA; Cramer DV
Xenotransplantation; 2007 Mar; 14(2):135-44. PubMed ID: 17381688
[TBL] [Abstract][Full Text] [Related]
33. Alpha-galactosyl antibody redistributes alpha-galactosyl at the surface of pig blood and endothelial cells.
Maruyama S; Cantu E3rd ; Pernis B; Galili U; Godman G; Stern DM; Andres G
Transpl Immunol; 1999 Jun; 7(2):101-6. PubMed ID: 10544440
[TBL] [Abstract][Full Text] [Related]
34. Natural protection from zoonosis by alpha-gal epitopes on virus particles in xenotransmission.
Kim NY; Jung WW; Oh YK; Chun T; Park HY; Lee HT; Han IK; Yang JM; Kim YB
Xenotransplantation; 2007 Mar; 14(2):104-11. PubMed ID: 17381684
[TBL] [Abstract][Full Text] [Related]
35. High antigen levels do not preclude B-cell tolerance induction to alpha1,3-Gal via mixed chimerism.
Haspot F; Bardwell PD; Zhao G; Sykes M
Xenotransplantation; 2008; 15(5):313-20. PubMed ID: 19134161
[TBL] [Abstract][Full Text] [Related]
36. Immune responses to alpha1,3 galactosyltransferase knockout pigs.
Puga Yung G; Schneider MK; Seebach JD
Curr Opin Organ Transplant; 2009 Apr; 14(2):154-60. PubMed ID: 19300259
[TBL] [Abstract][Full Text] [Related]
37. Non-depleting anti-CD4, but not anti-CD8, antibody induces long-term survival of xenogeneic and allogeneic hearts in alpha1,3-galactosyltransferase knockout (GT-Ko) mice.
Chong AS; Ma L; Yin D; Shen J; Blinder L; XiuLong X; Williams JW; Byrne G; Diamond LE; Logan JS
Xenotransplantation; 2000 Nov; 7(4):275-83. PubMed ID: 11081762
[TBL] [Abstract][Full Text] [Related]
38. Characteristics of α-Gal epitope, anti-Gal antibody, α1,3 galactosyltransferase and its clinical exploitation (Review).
Huai G; Qi P; Yang H; Wang Y
Int J Mol Med; 2016 Jan; 37(1):11-20. PubMed ID: 26531137
[TBL] [Abstract][Full Text] [Related]
39. Importance of the Gal alpha1-3 Gal antigen in discordant islet xenotransplantation: immunosuppression, which inhibits porcine islet xenograft rejection in ordinary mice, is equally effective in Gal-knockout mice.
Wennberg L; Song Z; Bennet W; Sandberg JO; Sundberg B; Thall A; Korsgren O
Transplantation; 2004 Apr; 77(8):1275-80. PubMed ID: 15114098
[TBL] [Abstract][Full Text] [Related]
40. Glycolipid studies in small intestine and pancreas of alpha1,3-galactosyltransferase knockout miniature swine: alpha1,3GALT-KO animals lack alphaGAL antigens and contain novel blood group H compounds.
Diswall M; Angström J; Schuurman HJ; Dor FJ; Rydberg L; Breimer ME
Transplant Proc; 2008 Mar; 40(2):543-6. PubMed ID: 18374124
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]